Study unravels why certain fishes went extinct 65 million... ( Large size and a fast bite spelled d...)

Study unravels why certain fishes went extinct 65 million years ago

Date:3/26/2009

Large size and a fast bite spelled doom for bony fishes during the last mass extinction 65 million years ago, according to a new study to be published March 31, 2009, in the Proceedings of the National Academy of Sciences.

Today, those same features characterize large predatory bony fishes, such as tuna and billfishes, that are currently in decline and at risk of extinction themselves, said Matt Friedman, author of the study and a graduate student in evolutionary biology at the University of Chicago.

"The same thing is happening today to ecologically similar fishes," he said. "The hardest hit species are consistently big predators."

Studies of modern fishes demonstrate that large body size is linked to large prey size and low rates of population growth, while fast-closing jaws appear to be adaptations for capturing agile, evasive preyin other words, other fishes. The fossil record provides some remarkable evidence supporting these estimates of function: fossil fishes with preserved stomach contents that record their last meals.

When an asteroid struck the earth at the end of the Cretaceous about 65 million years ago, the resultant impact clouded the earth in soot and smoke. This blocked photosynthesis on land and in the sea, undermined food chains at a rudimentary level, and led to the extinction of thousands of species of flora and fauna, including dinosaurs.

Scientists had speculated that during that interval large predatory fishes might have been more likely than other fishes to go extinct because they tended to have slowly increasing populations, live more spread out, take longer to mature, and occupy precarious positions at the tops of food chains. Today, ecologically similar fishes appear to be the least able to rebound from declining numbers due to overfishing.

To build the database he needed to test this prediction, Friedman traveled around the world measuring the body size an
'/>"/>

Contact: Greg Borzo
greg.borzo@uchospitals.edu
773-795-0892
University of Chicago Medical Center
Source:Eurekalert

1

GOOD

Page: 1 2 3
Related biology news :

1. CellThera and WPI advance in regeneration study
2. Innerscope Research(R) Uses Same-Day Results From Biometric Study to Identify Key Themes, Styles Behind Effective, Engaging Speaker Presentations
3. Lancet study supports new, highly effective treatment for blood disorder
4. Scots and Irish at greater risk of drink-related death, study shows
5. Pilot study shows effectiveness of new, low-cost method for monitoring hand hygiene compliance
6. DOE awards UGA $3.1 million to support complex carbohydrate study nationwide
7. AJCN study shows moderate alcohol consumption related to stronger bones
8. The genetics of fear: Study suggests specific genetic variations contribute to anxiety disorders
9. Study suggests salt might be natures antidepressant
10. Study of protein structures reveals key events in evolutionary history
11. American carnivores evolved to avoid each other, new study suggests

Post Your Comments:

Related Image:

Study unravels why certain fishes went extinct 65 million years ago

(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...

(Date:5/21/2013)... a class of pharmaceuticals can both prevent and treat ... as "TSPO ligands," are currently used for certain types ... TSPO ligand in young adult mice when pathology was ... pathology was quite severe," said lead researcher Christian Pike ... reduced measures of pathology and improved behavior at both ...

(Date:5/21/2013)... all types become most deadly when they metastasize and ... this stage, it becomes very difficult for doctors to ... Now, researchers at the University of Missouri have found ... tumor cells wherever they may be in the body. ... MU College of Veterinary Medicine, says being able to ...

Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2 Going green: Nation equipped to grow serious amounts of pond scum for fuel 3 Going green: Nation equipped to grow serious amounts of pond scum for fuel 4 Drugs found to both prevent and treat Alzheimer's disease in mice 2 MU researchers develop radioactive nanoparticles that target cancer cells 2

[0] Going green: Nation equipped to grow serious amounts of pond scum for fuel [0] Drugs found to both prevent and treat Alzheimer's disease in mice [0] MU researchers develop radioactive nanoparticles that target cancer cells

... MIT scientists have found a new way that DNA can ... discovering that a mold used to cast a metal tool ... shapes each showing distinct functional roles. Professor Manolis Kellis ... 1 issue of the journal Genes & Development that in ...

... Advanced Public Safety Minimizes ... Cost and Increases Accuracy -, WALL, N.J., ... International, Inc. (OTC Bulletin Board: BKYI), a leader ... Advanced Public Safety (APS), a leading provider of ...

... Cold Spring Harbor Laboratorys (CSHL) researcher Raffaella Sordella, Ph.D. ... Foundation to Conquer Lung Cancer. The two-year grant will ... class of genetic mutations that appear to be a ... of cancer deaths in the United States. The ...

Cached Biology News:MIT reports new twist in microRNA biology 2 Missouri Police Department Introduces Electronic Traffic Citations 2 Missouri Police Department Introduces Electronic Traffic Citations 3 Missouri Police Department Introduces Electronic Traffic Citations 4 Cold Spring Harbor Laboratory's lung cancer research program awarded $100,000 grant 2

MIT reports new twist in microRNA biology Missouri Police Department Introduces Electronic Traffic Citations Cold Spring Harbor Laboratory's lung cancer research program awarded $100,000 grant

(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...

(Date:5/21/2013)... study led by George Washington University Professor Tianshu ... ice in small droplets is strongly size-dependent, an ... nanoscale. The formation of ice at the nanoscale ... answer also has important implications for climate research ... ice from supercooled water is generally initiated by ...

(Date:5/21/2013)... Smarter Security, Inc., provider of premium, ... that Genzyme, a Sanofi company and leading biotech company, ... for a multi-use facility in the United States. With ... buildings, this latest order underscores the satisfaction and success ... device improving doorway access control. , “We ...

(Date:5/21/2013)... Md. , May 21, 2013 MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM. The presentation ...

Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2 Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3 Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4 Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2 Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2 Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3

[0] Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)[0] Study led by GW professor provides better understanding of water's freezing behavior at nanoscale [0] Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security [0] MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer

... ... ... ... ...

Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor

UBN-1 (C-20)...

Mouse HAI-1 Ectodomain MAb (Clone 199732)...

Human IL-29/IFN-lambda 1 Biotinylated Affinity Purified PAb...

Anti-Potassium Channel EAG-1 Immunogen: Synthetic peptide from the C-terminus of rat Kv10.1 (Accession Q63472). The immunogen sequence is identical in mouse and 14/16 residues identical in human...

Biology Products:

Goat Anti-Human UBN-1 (C-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.Rat Anti-Mouse HAI-1 Ectodomain Monoclonal Antibody, Unconjugated, Clone 199732 from R&D Systems Goat Anti-Human IL-29 / IFN-lambda 1 Polyclonal Antibody, Biotin Conjugated from R&D Systems Rabbit Anti-Rat Potassium Channel EAG-1 Antibody, Unconjugated from CHEMICON